C07C 211/40
Containing only non-condensed rings
Official title: containing only non-condensed rings
C07C211/40 (Containing only non-condensed rings) appears on 81 US grants and 97 published applications in this corpus.
Search patents in C07C- Granted patents
- 81
- Published applications
- 97
- Assignees
- 52
- Inventors
- 303
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 4 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 1 |
| 2003 | 2 | 3 |
| 2004 | 2 | 3 |
| 2005 | 1 | 2 |
| 2006 | 2 | 4 |
| 2007 | 3 | 5 |
| 2008 | 0 | 1 |
| 2009 | 3 | 3 |
| 2010 | 1 | 3 |
| 2011 | 4 | 2 |
| 2012 | 1 | 6 |
| 2013 | 0 | 11 |
| 2014 | 4 | 7 |
| 2015 | 6 | 9 |
| 2016 | 6 | 9 |
| 2017 | 7 | 0 |
| 2018 | 3 | 5 |
| 2019 | 5 | 1 |
| 2020 | 3 | 6 |
| 2021 | 3 | 4 |
| 2022 | 5 | 4 |
| 2023 | 2 | 2 |
| 2024 | 3 | 2 |
| 2025 | 1 | 2 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Substituted cyclohexyl compounds as NOP inhibitors2 Jun 2026US 12,643,888 B2Dart NeuroScience, LLC
- Potassium channel inhibitors19 Aug 2025US 12,391,644 B2Saniona A/S
- Compositions and methods for the treatment of cancer24 Sep 2024US 12,098,117 B2Duke University
- Potassium channel inhibitors11 Jun 2024US 12,006,289 B2Saniona A/S
- Substituted cyclohexyl compounds as NOP inhibitors2 Apr 2024US 11,945,808 B2Dart NeuroScience, LLC
- Novel potassium channel inhibitors19 Feb 2026US 2026/0049054 A1Saniona A/S
- Papd5 inhibitors, pharmaceutical compositions, and methods of treating neurological and cognitive disorders12 Feb 2026US 2026/0041655 A1Miralogx LLC
- Substituted cyclohexyl compounds as nop inhibitors20 Mar 2025US 2025/0092024 A1Dart NeuroScience, LLC
- Process of the preparation of hydroxylamine derivatives13 Feb 2025US 2025/0051269 A1Intervet Inc.
- Compositions and methods for the treatment of cancer12 Dec 2024US 2024/0409504 A1Duke University
Most cited
By later US patents
- Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases45US 6,071,970 ANPS Pharmaceuticals, Inc. · 2000
- Lysine specific demethylase-1 inhibitors and their use26US 8,722,743 B2Oryzon Genomics, S.A. · 2014
- Tetralone-based monoamine reuptake inhibitors24US 8,053,603 B2Sunovion Pharmaceuticals Inc. · 2011
- Method for preparing cyclopropylamines23US 6,043,393 ABayer Aktiengesellschaft · 2000
- Benzene derivatives, preparation method and pharmaceutical compositions containing same20US 6,482,986 B1Sanofi-Synthelabo · 2002